^
BIOMARKER:

ROS1 rearrangement

i
Other names: ROS1, ROS Proto-Oncogene 1 Receptor Tyrosine Kinase, V-Ros Avian UR2 Sarcoma Virus Oncogene Homolog 1, C-Ros Oncogene 1 Receptor Tyrosine Kinase, Proto-Oncogene Tyrosine-Protein Kinase ROS, Proto-Oncogene C-Ros-1, MCF3, ROS, V-Ros UR2 Sarcoma Virus Oncogene Homolog 1 (Avian), ROS Proto-Oncogene 1 Receptor Tyrosine Kinase, Transmembrane Tyrosine-Specific Protein Kinase, Receptor Tyrosine Kinase C-Ros Oncogene 1, C-Ros Receptor Tyrosine Kinase, Proto-oncogene C-Ros, C-Ros-1
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
ROS1 rearrangement
Non Small Cell Lung Cancer
brigatinib
Sensitive
:
C3
ESMO 2022 - 3 weeks - (New C3)
ROS1 rearrangement
Non Small Cell Lung Cancer
ceritinib
Sensitive
:
A2
ROS1 rearrangement
Non Small Cell Lung Cancer
crizotinib
Sensitive
:
A2
ROS1 rearrangement
Non Small Cell Lung Cancer
entrectinib
Sensitive
:
A2
ROS1 rearrangement
Non Small Cell Lung Cancer
lorlatinib
Sensitive
:
A2
ROS1 rearrangement
Lung Cancer
crizotinib
Sensitive
:
C2
ROS1 rearrangement
Lung Non-Squamous Non-Small Cell Cancer
crizotinib
Sensitive
:
C2
ROS1 rearrangement
Lung Adenocarcinoma
crizotinib
Sensitive
:
C3
ROS1 rearrangement
Lung Adenocarcinoma
Tyrosine kinase inhibitor
Sensitive
:
C3
ROS1 rearrangement
Non Small Cell Lung Cancer
Immunotherapy
Sensitive
:
C3
ROS1 rearrangement
Non Small Cell Lung Cancer
WX-0593
Sensitive
:
C3
ROS1 rearrangement
Lung Adenocarcinoma
ceritinib
Sensitive
:
C4